Optical Genome Mapping Market Poised to Hit USD 883.50 Million by 2032, with North America Dominating at 45% Share| DataM Intelligence

Leander, Texas- The global optical genome mapping market size was valued at USD 131.50 million in 2023. It is estimated to reach USD 883.50 million by 2032, growing at a CAGR of 24.10% during the forecast period (2024-2032).

The optical genome mapping market is growing due to the advancements in genomic research, aiding in the study of complex genetic variations and diseases. Additionally, the growing prevalence of genetic disorders is driving the need for advanced genomic technologies like OGM for accurate diagnosis and treatment.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/optical-genome-mapping-market?pratik

United states industry development
✅ September 2025: Bionano Genomics expanded clinical adoption of its optical genome mapping (OGM) platform for hematologic malignancy diagnostics across major U.S. hospitals, pushing forward precision medicine applications in cancer diagnostics.

✅ August 2025: Mayo Clinic launched a precision medicine program integrating OGM into routine cancer genomics workflows, enhancing early disease detection and personalized treatment strategies.

✅ June 2025: Johns Hopkins University advanced OGM-based research for rare disease genomics, backed by federal research grants, underscoring growing academic investment in this technology.

✅ May 2025: Invitae Corporation announced pilot programs employing OGM for inherited genetic disorder screening, marking progress towards clinical implementation for genetic testing.

✅ July 2025: PacBio partnered with biotech firms to combine OGM with long-read sequencing for comprehensive genome structural analysis, advancing hybrid genomic technologies.

Japan industry development
✅ September 2025: RIKEN integrated OGM platforms into national genome research initiatives, accelerating discoveries in genomic structural variants relevant to rare diseases and cancer.

✅ August 2025: Tokyo University Hospital started clinical trials applying OGM for leukemia and lymphoma diagnostics, signaling adoption in clinical oncology practice.

✅ July 2025: Sysmex Corporation partnered with biotech companies to develop automated OGM workflows for hospital laboratories, improving efficiency in genomic diagnostics.

✅ June 2025: Kyoto University researchers utilized OGM to study genetic instability in cancer models, advancing translational cancer genomics research.

✅ May 2025: Fujifilm collaborated with Japanese research institutes to expand OGM-based precision medicine applications, promoting innovation in genomic healthcare.

Recent m&a data:-

⇥ Bionano Genomics acquired BioDiscovery Inc. in October 2022 for $100 million, integrating BioDiscovery's NxClinical software to enhance optical genome mapping capabilities.

⇥ Hitachi High-Tech Corporation strengthened its genomic analysis portfolio by acquiring Nabsys, expanding its optical genome mapping solutions.

⇥ Thermo Fisher Scientific expanded its bioproduction capabilities via acquisition deals supporting genomic workflows, aiding end-to-end sample-to-answer solutions linked to optical genome mapping.

⇥ Illumina advanced multi-omics technologies that complement optical genome mapping, partly driven by strategic partnerships and investments in AI-driven genomics.

🔹 Market segmentation with Market share -

⇥ Product Segmentation
Instruments: Dominant segment with about 41.1% market share in 2025, driven by adoption in clinical diagnostics and research.

Consumables and Reagents: Fastest-growing segment, growing at a CAGR of around 25.9%, fueled by expanding installed base and repeat tests.

Services: Important for supporting genomic analysis workflows and data interpretation.

Software: Increasingly critical for data analysis, genome assembly, and structural variant detection.

⇥ Application Segmentation
Clinical Diagnostics: Significant share (37%), driven by use in oncology, rare disease diagnostics, and genetic testing.

Research: Growing segment, especially in genomics research initiatives and precision medicine development.

⇥ Technique Segmentation
Structural Variant Detection: Largest technique segment with approximately 44.3% market share due to its importance in identifying large-scale genome variations tied to diseases.

Genome Assembly and Microbial Strain Typing: Emerging segments with expanding adoption in research.

⇥ End-user Segmentation
Hospitals & Clinical Laboratories: Major users in diagnostics applications.

Biotechnology & Pharmaceutical Companies: Utilize OGM for research and drug development.

Academic Research Institutes: Important for fundamental and applied genome research.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=optical-genome-mapping-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

🔹 Regional insights-

⇥ North America:The largest regional market, holding approximately 45% share in 2023.
Growth is driven by advanced technological infrastructure, high R&D investments in genomics, the presence of major biotechnology and pharmaceutical companies, strong government funding, and supportive regulatory environments.

⇥ Asia‐Pacific:The fastest-growing region, projected with a high compound annual growth rate (CAGR), with some estimates placing China alone at a significant share of the regional market.
Growth is fueled by rapid industrialization, increasing investments in genomic research, rising awareness of genetic diseases, growing precision medicine initiatives (e.g., in China and Japan), and a large and expanding consumer base.

⇥ Europe:A significant and mature market with steady growth. Europe's growth is driven by strong government support for genomics research, the presence of leading biotechnology companies, and a well-established industrial base and regulatory framework that encourages the adoption of OGM solutions.

🔹 Growth Drivers:-

⇥ Technological Advancements:
Continuous innovation in high-resolution imaging, labeling technologies, and computational analytics is enhancing the precision, speed, and reliability of optical genome mapping. The integration of OGM with other technologies like Next-Generation Sequencing (NGS) and Artificial Intelligence (AI) further increases efficiency and accuracy.

⇥ Growing Demand for Precision Medicine:
OGM's ability to identify genetic variations associated with various diseases allows for the development of personalized treatment plans. This aligns with the broader trend towards precision medicine, where treatments are tailored to an individual's genetic makeup, potentially revolutionizing healthcare and improving patient outcomes.

⇥ Increasing Prevalence of Genetic Disorders and Cancer:
The rising prevalence of genetic disorders and cancer globally fuels the demand for OGM. In cancer research, for example, OGM plays a critical role in identifying therapeutic targets and resistance mechanisms.

⇥ Limitations of Traditional Cytogenetic Methods:
Traditional cytogenetic methods are often limited in their ability to accurately analyze large genomic regions and detect complex structural variations. OGM, by providing high-resolution visualization, overcomes these limitations and offers a more comprehensive analysis, making it a valuable tool for diagnostics.

⇥ Expanding Research and Clinical Applications:
The adoption of OGM is growing in both academic research and clinical diagnostics. Researchers use it to gain a better understanding of genome structure, while clinicians are integrating it into routine diagnostics for hematological malignancies and other genetic disorders.

🔹 Emerging players :-

⇥ Nabsys: Specializes in products for analyzing genomic structural variations. It was recently acquired by Hitachi High-Tech in August 2024 to strengthen its offerings in the genomic analysis space.

⇥ Nucleome Informatics Private Limited: An India-based company focusing on DNA sequencing, bioinformatics, and multiomics services.

⇥ Praxis Genomics, LLC: A US-based genomic services provider and a competitor in the OGM market.

⇥ Genomic Vision: Specializes in molecular combing technology and is a direct competitor in the optical mapping space.

⇥ MedGenome: An India-based company offering DNA sequencing, bioinformatics, and multiomics services, with significant funding and recent expansion efforts in the US.

⇥ KromaTiD, Inc.: A company involved in the market, focusing on advanced chromosome analysis and high-resolution imaging.

⇥ OpGen, Inc.: An established player in the market offering solutions for infectious disease analysis.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/optical-genome-mapping-market?pratik

🔹 Key Investment:

Bionano Genomics raised $150 million in a public offering in early 2025 to expand its clinical and research application portfolio for optical genome mapping technology.

NIH and other government agencies granted approximately $50 million in 2025 to U.S.-based genomic research institutions for projects involving optical genome mapping, supporting technology adoption.

Invitae Corporation invested $75 million into integrating optical genome mapping with long-read sequencing platforms to advance comprehensive genomic structural analysis.

Several biotech startups developing software and consumables for optical genome mapping collectively raised over $100 million in venture funding in 2025, driven by the precision medicine trend.

Strategic partnerships between instrument manufacturers and pharmaceutical companies have attracted investments totaling about $60 million for co-development of diagnostics and therapeutics utilizing genome mapping data.

Request for 2 Days FREE Trial Access:

https://www.datamintelligence.com/reports-subscription?pratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.